Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival
Annals of Hematology, 08/17/2012
Santamaria C et al. – Detectable WT1 expression levels, and low TET2 and low IER3 expression in peripheral blood showed a strong association with adverse prognosis in myelodysplastic syndromes (MDS) patients at diagnosis. However, WT1 was the only molecular marker displaying an independent prognostic value in both overall survival (OS) and treatment–free (TFS).
